The future of multifunctional liposomes in cancer therapy looks promising. Advances in nanotechnology and molecular biology are expected to enhance their specificity, efficacy, and safety. Emerging techniques such as CRISPR gene editing and personalized medicine could further optimize liposomal formulations for individual patients. Research is also ongoing to develop stimuli-responsive liposomes that can release their payload in response to specific triggers such as pH, temperature, or enzymatic activity.
